Literature DB >> 20980520

Persistent Friend virus replication and disease in Apobec3-deficient mice expressing functional B-cell-activating factor receptor.

Mario L Santiago1, Diana S Smith, Bradley S Barrett, Mauricio Montano, Robert L Benitez, Roberta Pelanda, Kim J Hasenkrug, Warner C Greene.   

Abstract

Rfv3 is an autosomal dominant gene that influences the recovery of resistant mice from Friend retrovirus (FV) infection by limiting viremia and promoting a more potent neutralizing antibody response. We previously reported that Rfv3 is encoded by Apobec3, an innate retrovirus restriction factor. However, it was recently suggested that the Rfv3 susceptible phenotype of high viremia at 28 days postinfection (dpi) was more dominantly controlled by the B-cell-activating factor receptor (BAFF-R), a gene that is linked to but located outside the genetically mapped region containing Rfv3. Although one prototypical Rfv3 susceptible mouse strain, A/WySn, indeed contains a dysfunctional BAFF-R, two other Rfv3 susceptible strains, BALB/c and A.BY, express functional BAFF-R genes, determined on the basis of genotyping and B-cell immunophenotyping. Furthermore, transcomplementation studies in (C57BL/6 [B6] × BALB/c)F(1) and (B6 × A.BY)F(1) mice revealed that the B6 Apobec3 gene significantly influences recovery from FV viremia, cellular infection, and disease at 28 dpi. Finally, the Rfv3 phenotypes of prototypic B6, A.BY, A/WySn, and BALB/c mouse strains correlate with reported Apobec3 mRNA expression levels. Overall, these findings argue against the generality of BAFF-R polymorphisms as a dominant mechanism to explain the Rfv3 recovery phenotype and further strengthen the evidence that Apobec3 encodes Rfv3.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20980520      PMCID: PMC3014173          DOI: 10.1128/JVI.01838-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21.

Authors:  A Cariappa; M Tang; C Parng; E Nebelitskiy; M Carroll; K Georgopoulos; S Pillai
Journal:  Immunity       Date:  2001-05       Impact factor: 31.745

2.  Phenotypic and genetic characterization of a unique B lymphocyte deficiency in strain A/WySnJ mice.

Authors:  D J Miller; C E Hayes
Journal:  Eur J Immunol       Date:  1991-05       Impact factor: 5.532

3.  Identification of a non-H-2 gene (Rfv-3) influencing recovery from viremia and leukemia induced by Friend virus complex.

Authors:  B Chesebro; K Wehrly
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

Review 4.  The coupling of alternative splicing and nonsense-mediated mRNA decay.

Authors:  Liana F Lareau; Angela N Brooks; David A W Soergel; Qi Meng; Steven E Brenner
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

5.  Adaptive evolution of Mus Apobec3 includes retroviral insertion and positive selection at two clusters of residues flanking the substrate groove.

Authors:  Bradley Sanville; Michael A Dolan; Kurt Wollenberg; Yuhe Yan; Carrie Martin; Man Lung Yeung; Klaus Strebel; Alicia Buckler-White; Christine A Kozak
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

6.  Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction.

Authors:  Eric W Refsland; Mark D Stenglein; Keisuke Shindo; John S Albin; William L Brown; Reuben S Harris
Journal:  Nucleic Acids Res       Date:  2010-03-22       Impact factor: 16.971

7.  Rfv-1 and Rfv-2, two H-2-associated genes that influence recovery from Friend leukemia virus-induced splenomegaly.

Authors:  B Chesebro; K Wehrly
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

8.  Species-specific restriction of apobec3-mediated hypermutation.

Authors:  Edward P Browne; Dan R Littman
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

9.  Murine BAFF-receptor residues 168-175 are essential for optimal CD21/35 expression but dispensable for B cell survival.

Authors:  Christopher G Mayne; Ian J Amanna; Colleen E Hayes
Journal:  Mol Immunol       Date:  2009-10-07       Impact factor: 4.407

10.  BayGenomics: a resource of insertional mutations in mouse embryonic stem cells.

Authors:  Doug Stryke; Michiko Kawamoto; Conrad C Huang; Susan J Johns; Leslie A King; Courtney A Harper; Elaine C Meng; Roy E Lee; Alice Yee; Larry L'Italien; Pao-Tien Chuang; Stephen G Young; William C Skarnes; Patricia C Babbitt; Thomas E Ferrin
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

View more
  18 in total

1.  Innate immune sensing of retroviral infection via Toll-like receptor 7 occurs upon viral entry.

Authors:  Melissa Kane; Laure K Case; Christine Wang; Leonid Yurkovetskiy; Stanislav Dikiy; Tatyana V Golovkina
Journal:  Immunity       Date:  2011-06-30       Impact factor: 31.745

2.  Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response.

Authors:  Kalani Halemano; Bradley S Barrett; Karl J Heilman; Thomas E Morrison; Mario L Santiago
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

3.  Systemic Expression of a Viral RdRP Protects against Retrovirus Infection and Disease.

Authors:  Caitlin M Miller; Bradley S Barrett; Jianfang Chen; James H Morrison; Caleb Radomile; Mario L Santiago; Eric M Poeschla
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

4.  APOBEC3A functions as a restriction factor of human papillomavirus.

Authors:  Cody J Warren; Tao Xu; Kejun Guo; Laura M Griffin; Joseph A Westrich; Denis Lee; Paul F Lambert; Mario L Santiago; Dohun Pyeon
Journal:  J Virol       Date:  2014-10-29       Impact factor: 5.103

5.  IFN-α treatment inhibits acute Friend retrovirus replication primarily through the antiviral effector molecule Apobec3.

Authors:  Michael S Harper; Bradley S Barrett; Diana S Smith; Sam X Li; Kathrin Gibbert; Ulf Dittmer; Kim J Hasenkrug; Mario L Santiago
Journal:  J Immunol       Date:  2013-01-11       Impact factor: 5.422

Review 6.  Humoral immunity in the Friend retrovirus infection model.

Authors:  Kalani Halemano; Michael S Harper; Kejun Guo; Sam X Li; Karl J Heilman; Bradley S Barrett; Mario L Santiago
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

7.  Ribonuclease L is not critical for innate restriction and adaptive immunity against Friend retrovirus infection.

Authors:  Sam X Li; Bradley S Barrett; Michael S Harper; Karl J Heilman; Kalani Halemano; Amanda K Steele; Kejun Guo; Robert H Silverman; Mario L Santiago
Journal:  Virology       Date:  2013-05-29       Impact factor: 3.616

8.  Immunoglobulin somatic hypermutation by APOBEC3/Rfv3 during retroviral infection.

Authors:  Kalani Halemano; Kejun Guo; Karl J Heilman; Bradley S Barrett; Diana S Smith; Kim J Hasenkrug; Mario L Santiago
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

9.  Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo.

Authors:  Bradley S Barrett; Kejun Guo; Michael S Harper; Sam X Li; Karl J Heilman; Nicholas O Davidson; Mario L Santiago
Journal:  Virology       Date:  2014-10-07       Impact factor: 3.616

10.  Tetherin promotes the innate and adaptive cell-mediated immune response against retrovirus infection in vivo.

Authors:  Sam X Li; Bradley S Barrett; Karl J Heilman; Ronald J Messer; Rachel A Liberatore; Paul D Bieniasz; George Kassiotis; Kim J Hasenkrug; Mario L Santiago
Journal:  J Immunol       Date:  2014-05-28       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.